List view / Grid view

Production

 

article

Regulatory non-compliance business interruptions

29 October 2019 | By

Loss of manufacturing capability as a result of regulatory non-compliance can have a devastating impact on biopharma or medical device manufacturers. In this article, Jenny Yu shares real-life examples from the industry and highlights the downstream effects of these business interruptions.